Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy. (2025). Translation: The University of Toledo Journal of Medical Sciences, 13(S3). https://doi.org/10.46570/utjms-2025-1354